Hypogonadism in male thalassemia major patients: pathophysiology, diagnosis and treatment

Hypogonadism in male thalassemia major patients: pathophysiology, diagnosis and treatment


  • Vincenzo de Sanctis Pediatric and Adolescent Outpatient Clinic, Quisisana Hospital, Ferrara, Italy
  • Ashraf T Soliman Department of Pediatrics, Division of Endocrinology, Alexandria University Children's Hospital, Alexandria, Egypt
  • Mohamed A Yassin Hematology Consultant, Hematology and BMT Department, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar
  • Salvatore Di Maio Emeritus Director in Pediatrics, Santobono-Pausilipon Hospital, Naples, Italy
  • Shahina Daar Department of Haematology, College of Medicine and Health Sciences, Sultan Qaboos University, Sultanate of Oman
  • Heba Elsedfy Department of Pediatrics, Ain Shams University, Cairo, Egypt
  • Nada Soliman Student's Hospital, Ministry of Health, Alexandria, Egypt
  • Christos Kattamis First Department of Paediatrics, National Kapodistrian University of Athens, Athens, Greece


Thalassaemia, hypogonadism, iron overload, chelation therapy, spermatogenesis, fertility in males


Failure of pubertal growth, delay or absence of sexual development, infertility and sexual dysfunction due to hypogonadism and defective spermatogenesis are frequent and well recognized disturbances among male patients with transfusion dependent (TD) thalassaemia major (β-thal). These problems are attributed mainly to the damage caused by chronic anaemia and the deposition of excess iron in the pituitary gland and testicles. This is a short review of male pubertal disorders in patients with β-thal written by pediatric endocrinologists and haematologists with an interest and active involvement, in the diagnosis and management of these complications in this group of patients. A vigilant clinical evaluation of growth and puberty, as well as an appropriate hormonal evaluation in poly-transfused (TD β-thal) patients is strongly recommended for early detection and treatment of endocrine dysfunction. Of crucial importance also, is the implementation of an efficient chelation regime from early life, to prevent severe iron load and permanent damage to the endocrine glands, particularly those responsible for gonadal function.




How to Cite

de Sanctis V, Soliman AT, Yassin MA, Di Maio S, Daar S, Elsedfy H, et al. Hypogonadism in male thalassemia major patients: pathophysiology, diagnosis and treatment. Acta Biomed [Internet]. 2018 Feb. 16 [cited 2024 Jul. 22];89(2-S):6-15. Available from: https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/7082